WIESEN IRVING L 4
4 · Pharma-Bio Serv, Inc. · Filed Mar 28, 2023
Insider Transaction Report
Form 4
WIESEN IRVING L
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-24$1.00/sh+20,000$20,000→ 64,335 total - Exercise/Conversion
Common Stock
2023-03-24$0.76/sh+20,000$15,200→ 67,241 total - Exercise/Conversion
Stock Option
2023-03-24−20,000→ 0 totalExercise: $1.00Exp: 2024-01-10→ Common Stock (20,000 underlying) - Tax Payment
Common Stock
2023-03-24$1.17/sh−12,991$15,199→ 54,250 total - Exercise/Conversion
Stock Option
2023-03-24−20,000→ 0 totalExercise: $0.76Exp: 2025-01-10→ Common Stock (20,000 underlying) - Tax Payment
Common Stock
2023-03-24$1.17/sh−17,094$20,000→ 47,241 total
Footnotes (3)
- [F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
- [F2]The option vested in two equal installments on July 10, 2019 and July 10, 2020.
- [F3]The option vested in two equal installments on July 10, 2020 and July 10, 2021.